The Animal Biotechnology Market Report is Segmented by Product Type (Biologics, Diagnostics, and More), Application (Disease Diagnosis and More), Animal Type (Livestock Animals [Cattle and More] and Companion Animals [Dogs and More]), End-User (Laboratories and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global animal biotechnology market was estimated at 27 billion U.S. dollars in 2023. Of that, North America owned the largest share, with around 35 percent, followed by Asia-Pacific, with around 29 percent.

Global Animal Biotechnology Market size is growing with a CAGR of 9.1% in the prediction period and it crosses US$ 58.05 Bn by 2032 from US$ 31.55 Bn in 2025.

Market Research Intellect presents the Animal Biotechnology Market Report-estimated at USD 23.5 billion in 2024 and predicted to grow to USD 42.1 billion by 2033, with a CAGR of 7.6% over the forecast period. Gain clarity on regional performance, future innovations, and major players worldwide.

Global Animal Biotechnology Market is valued at USD 31 billion, driven by genetic engineering advancements, animal health demand, and precision farming, with key growth in livestock and diagnostics.

Snapshot img

Animal Biotechnology Market Size 2025-2029

The animal biotechnology market size is forecast to increase by USD 4.47 billion at a CAGR of 3.3% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing strategies of market players to expand their product portfolios and geographical reach. This trend is particularly evident in the development of innovative solutions for animal health and productivity. However, the market also faces challenges, including the increasing prevalence of animal diseases, which necessitate the need for more accurate and timely diagnostic tests. This presents an opportunity for companies to invest in research and development of advanced diagnostic tools and services. Despite this potential, the market growth is hindered by the lack of a skilled workforce capable of performing complex diagnostic tests. This labor shortage can be addressed through collaborations between academia, industry, and governments to train and educate the next generation of animal biotechnology professionals. Companies seeking to capitalize on market opportunities and navigate challenges effectively should focus on building a strong workforce, investing in research and development, and collaborating with industry partners to stay ahead of the competition. By doing so, they will be well-positioned to meet the growing demand for animal health solutions and contribute to the overall growth of the market.

What will be the Size of the Animal Biotechnology Market during the forecast period?

Request Free SampleThe market encompasses a range of applications, including genetic engineering for enhancing animal productivity, reproductive technologies, and the development of animal-based goods and derived products. This sector is driven by the growing demand for animal health solutions, as well as the potential for animal biotechnology in cancer treatment and pharmaceutical development. Public health systems and the animal feed sector also benefit from biotech solutions, such as disease resistance, therapeutic proteins, and diagnostic tests. Molecular biology plays a crucial role in advancing animal health through the identification and prevention of zoonotic diseases and the development of vaccines and drug treatments. Additionally, animal welfare and health management are key areas of focus, with biotech products and cloning techniques contributing to preventative care and protein synthesis. Overall, the market is experiencing significant growth, with ongoing research and innovation in areas such as disease treatment, vaccine development, and animal agriculture efficiency.

How is this Animal Biotechnology Industry segmented?

The animal biotechnology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductDrugsVaccinesDiagnostic testsOthersAnimal TypeLivestock/productionCompanionTechnologyCRISPR-Cas9Gene transferGenome editingRNA interferenceNanotechnologyProduct TypeCloning servicesEmbryo biotechnologyGene editingIn vitro fertilization (IVF)Marker assisted selection (MAS)GeographyNorth AmericaUSCanadaEuropeFranceGermanyUKAsiaRest of World (ROW)

By Product Insights

The drugs segment is estimated to witness significant growth during the forecast period.Animal biotechnology encompasses various applications, including genetic composition, genetic engineering, reproductive technologies, animal health, animal-based goods, and animal-derived products. Genetic modification through techniques like electroporation method and random genomic integration is used to create genetically engineered animals with better nutritional profiles, disease resistance, and improved immunological responses. In vitro fertilization and genomic analytic tools are employed in clinical settings for genetic resources and diagnostics tests. Animal agriculture efficiency is enhanced through selective breeding and molecular biology, leading to improvements in cattle health, disease resistance, and the production of animal protein. Animal feed sector relies on feed additives and diagnostics tests for disease prevention and monitoring. Veterinary laboratories and point-of-care testing facilitate quick and accurate diagnosis of animal diseases, such as zoonotic diseases like foot and mouth disease (FMD), salmonella, swine fever, avian influenza, and bovine respiratory disease (BRD). Genetically modified organisms, including genetically altered transgenic animals, are used for cancer treatment, public health systems, and drug development. The use of these technologies in animal health and agriculture is crucial for maintaining animal welfare and ensuring food security.

Get a glance at the market report of share of various segments Request Free Sample

The Drugs segment was valued at USD 7.61

The Global Animal Biotechnology Market size was valued at USD 24.20 billion in 2023 and is projected to reach USD 44.81 billion by 2032, exhibiting a CAGR of 9.2 % during the forecasts period.

Global Animal Biotechnology Market size and share are expected to exceed USD 56,949.40 Million by 2032, with a compound annual growth rate (CAGR) of 8.8% during the forecast period.

Global animal biotechnology market size was approximately USD 20.14 billion in 2024 & is projected to reach at USD 58.23 billion by 2034.(CAGR) of 11.20%

The global animal biotechnology market size reached a value of about USD 27.75 Billion in 2024. The market is growing at a rapid rate and is likely to register a CAGR of about 7.00% in the forecast period of 2025-2034. The market is likely to attain a value of USD 54.59 Billion by 2034.

Animal Health Biotechnology Market Outlook

According to our latest research, the global animal health biotechnology market size reached USD 22.8 billion in 2024 and is projected to grow at a robust CAGR of 8.9% during the forecast period, reaching approximately USD 48.5 billion by 2033. The market is witnessing significant expansion, driven by increasing investments in advanced veterinary care, rising prevalence of zoonotic diseases, and growing demand for high-quality animal-derived products. As per our in-depth analysis, technological advancements and the integration of biotechnology in animal health are key factors shaping the market’s trajectory.

A primary growth factor for the animal health biotechnology market is the rising global awareness regarding animal welfare and the critical role of animal health in food safety and public health. Governments and private stakeholders are making substantial investments in research and development to combat infectious diseases, improve livestock productivity, and ensure the health of companion animals. The emergence of novel biotechnological solutions, such as recombinant vaccines, advanced diagnostics, and genetic engineering, has considerably enhanced the efficacy and precision of animal healthcare interventions. This shift toward preventive healthcare, coupled with stringent regulations on antibiotic usage in food animals, is fostering innovation and adoption of biotechnology-based products across the industry.

Another significant driver is the increasing incidence of zoonotic diseases, which has heightened the focus on early detection, monitoring, and management of animal-borne pathogens. The COVID-19 pandemic has further underscored the importance of robust animal health systems, leading to accelerated adoption of molecular diagnostic tools and next-generation sequencing technologies. Additionally, the growing trend of pet humanization, especially in developed markets, is fueling demand for advanced therapeutics and wellness products for companion animals. Companies are responding with targeted biotechnological solutions, including immunotherapies, stem cell treatments, and nutraceuticals, to cater to the evolving expectations of pet owners and livestock producers alike.

The expansion of the animal health biotechnology market is also being propelled by the globalization of animal trade and the increasing consumption of animal protein. Emerging economies in Asia Pacific and Latin America are witnessing rapid industrialization of animal agriculture, creating a substantial need for innovative health management solutions. Regulatory harmonization and the establishment of international standards for animal health products are further streamlining market access and facilitating cross-border collaborations. However, challenges such as high R&D costs, complex regulatory landscapes, and limited access to advanced technologies in low-income regions persist, necessitating strategic partnerships and sustained investment in capacity building.

Regionally, North America dominated the animal health biotechnology market in 2024, accounting for the largest revenue share, followed by Europe and Asia Pacific. The United States, in particular, has been at the forefront of technological innovation and product commercialization, supported by a strong network of research institutions, veterinary hospitals, and industry players. Meanwhile, Asia Pacific is anticipated to exhibit the fastest growth over the forecast period, driven by increasing investments in animal health infrastructure, rising disposable incomes, and expanding livestock populations. Latin America and the Middle East & Africa are also emerging as lucrative markets, although they face unique challenges related to infrastructure and regulatory frameworks.

Product Type Analysis

The product type segment of the animal health biotechnology market encompasses vaccines, diagnostics, therapeutics, feed additives, and others. Vaccines represent a cornerstone of preventive animal healthcare, with recombinant and DNA-based vaccines gaining traction due to their safety profile and efficacy against a broad spectrum of pathogens. In 2024, vaccines accounted for a significant portion of the market share, driven by increasing immunization programs in livestock and companion animals. The rising threat of zoonotic diseases and the need to reduce antibiotic dependency have further accelerated vaccine adoption worldwide. Companies are investing in next-generation vaccine tec

Animal Biotechnology Market Size, Trends and Insights By Product (Diagnostics Tests, Vaccines and Drugs, Reproductive and Genetic, Feed Additives, Others), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By End User (Veterinary Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

Global Animal Biotechnology Market was valued at USD 31,474.2 Million in 2024 and is expected to reach USD 74,086.0 Million by 2033, at a CAGR of 8.94% during the forecast period 2024 – 2033.

Animal biotechnology is the use of biotechnological methods and procedures to change the genetic composition, physiology, and features of animals for a variety of objectives, including agriculture, medicine, and industry.

This discipline incorporates a broad spectrum of technologies that include genetic engineering, cloning, transgenesis, and reproductive technologies to enhance animal health, welfare, and production.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=41874

The global animal biotechnology market is booming, projected to reach $25 billion by 2033, driven by increased demand for animal healthcare, advanced diagnostics, and food safety concerns. Explore market trends, key players (Bayer, Merck, Zoetis), and regional growth in this comprehensive analysis.

Animal Biotechnology Market size was valued at USD 28.93 Bn in 2024 & is predicted to grow at USD 58.59 Bn by 2032 at 9.22% CAGR from 2025 - 2034

The Animal Biotechnology market, a dynamic sector at the intersection of agriculture, genetics, and veterinary science, is rapidly evolving to address various challenges faced by the global food supply chain, animal health, and environmental sustainability. This industry leverages cutting-edge techniques such as gen

Global Animal Biotechnology market size 2025 was XX Million. Animal Biotechnology Industry compound annual growth rate (CAGR) will be XX% from 2025 till 2033.

Global Animal Biotechnology Market has valued at USD 22.70 billion in 2022 and is anticipated to project impressive growth.

Global Animal Reproductive Biotech Market is segmented by Application (Cattle_Swine_Sheep_Goats_Horses), Type (Artificial Insemination_Embryo Transfer_Genetic Testing_Cloning_In-Vitro Fertilization), and Geography (North America_ LATAM_ West Europe_Central & Eastern Europe_ Northern Europe_ Southern Europe_ East Asia_ Southeast Asia_ South Asia_ Central Asia_ Oceania_ MEA)

Saudi Arabia Animal Biotechnology Market is expected to reach USD 92.16 Million by 2030 with a CAGR of 3.50% during the forecast period.

Marktonderzoek Intellect presenteert de Market-marktrapport voor dierenbiotechnologie geschat op USD 23,5 miljard in 2024 en naar verwachting naar USD 42,1 miljard groeien tegen 2033, met een CAGR van 7,6% gedurende de voorspellingsperiode. Krijg duidelijkheid over regionale prestaties, toekomstige innovaties en grote spelers wereldwijd.